Literature DB >> 2754560

Abnormal brain-stem function (brain-stem auditory evoked response) correlates with acoustic cry features in term infants with hyperbilirubinemia.

B R Vohr1, B Lester, G Rapisardi, C O'Dea, L Brown, M Peucker, W Cashore, W Oh.   

Abstract

We hypothesized that changes in brain-stem auditory evoked responses related to bilirubin would be associated with changes in cry because of the anatomic proximity in the brain stem of cranial nerves 8 (auditory) and 9 to 12 (vagal complex, which controls cry). Brain-stem auditory evoked responses and computerized cry analysis were used to study the concurrent effects of moderate hyperbilirubinemia on auditory function and cry. Fifty term infants were divided equally into two groups on the basis of serum bilirubin concentrations: low (less than 8 mg/dl; 136) mumol/L and moderate (10 to 20 mg/dl, 170 to 342 mumol/L). Forty-three infants had successful tracings of brain-stem auditory evoked responses recorded with a Cadwell model 5200A evoked response unit during two successive trials, and a cry recording of each infant was analyzed by computer. The moderate serum bilirubin group had an increase in percent cry phonation (p less than 0.02) and an increase in the variability of the first formant (p less than 0.04) in comparison with the low serum bilirubin group. Serum bilirubin values correlated positively with brain-stem conduction time (r = 0.36, p less than 0.01), percent phonation (r = 0.42, p less than 0.004), and variability of the first formant (r = 0.39, p less than 0.02). Percent phonation, the voiced component produced by increased neural control, correlated with the interpeak of waves latencies I to III (r = 0.32, p less than 0.03) and brain-stem conduction time (wave I to V) (r = 0.35, p less than 0.01). We conclude that hyperbilirubinemia affects adjoining areas of the brain stem that control hearing and cry production.

Entities:  

Mesh:

Year:  1989        PMID: 2754560     DOI: 10.1016/s0022-3476(89)80090-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

Review 1.  The blood-brain barrier and bilirubin encephalopathy.

Authors:  R P Wennberg
Journal:  Cell Mol Neurobiol       Date:  2000-02       Impact factor: 5.046

2.  Auditory brainstem responses in neonatal hyperbilirubinemia and effect of therapy.

Authors:  Ravi Sharma; Neelam Grover; Naveen Sankhyan; M L Sharma
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2006-10

3.  Effects of bilirubin on visual evoked potentials in term infants.

Authors:  Y J Chen; W M Kang
Journal:  Eur J Pediatr       Date:  1995-08       Impact factor: 3.183

Review 4.  What constitutes a "safe" level of bilirubin concentration in preterm and full term infants?

Authors:  N K Anand; A K Gupta
Journal:  Indian J Pediatr       Date:  1993 Jul-Aug       Impact factor: 1.967

Review 5.  Apnea in acute bilirubin encephalopathy.

Authors:  Sanjiv B Amin; Vinod K Bhutani; Jon F Watchko
Journal:  Semin Perinatol       Date:  2014-09-17       Impact factor: 3.300

Review 6.  Management of neonatal hyperbilirubinaemia and prevention of kernicterus.

Authors:  F F Rubaltelli; P F Griffith
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

7.  Melody complexity of infants' cry and non-cry vocalisations increases across the first six months.

Authors:  Kathleen Wermke; Michael P Robb; Philip J Schluter
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

8.  Neurobehavior of term neonates with neonatal hyperbilirubinemia.

Authors:  Thirunavukkarasu Arun Babu; B Vishnu Bhat; Noyal Mariya Joseph
Journal:  J Pediatr Neurosci       Date:  2013-01

Review 9.  Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels.

Authors:  Vinod K Bhutani; Alvin Zipursky; Hannah Blencowe; Rajesh Khanna; Michael Sgro; Finn Ebbesen; Jennifer Bell; Rintaro Mori; Tina M Slusher; Nahed Fahmy; Vinod K Paul; Lizhong Du; Angela A Okolo; Maria-Fernanda de Almeida; Bolajoko O Olusanya; Praveen Kumar; Simon Cousens; Joy E Lawn
Journal:  Pediatr Res       Date:  2013-12       Impact factor: 3.756

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.